Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Accounts Payables: 2011-2019

Historic Accounts Payables for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Mar 2019 value amounting to $6.3 million.

  • EyePoint Pharmaceuticals' Accounts Payables rose 128.91% to $6.3 million in Q1 2019 from the same period last year, while for Mar 2019 it was $6.3 million, marking a year-over-year increase of 128.91%. This contributed to the annual value of $2.9 million for FY2018, which is 189.37% up from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Accounts Payables stood at $6.3 million for Q1 2019, which was up 139.32% from $2.6 million recorded in Q4 2018.
  • EyePoint Pharmaceuticals' Accounts Payables' 5-year high stood at $6.3 million during Q1 2019, with a 5-year trough of $303,000 in Q4 2015.
  • For the 3-year period, EyePoint Pharmaceuticals' Accounts Payables averaged around $2.6 million, with its median value being $2.6 million (2018).
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Accounts Payables declined by 29.68% in 2016, and later skyrocketed by 272.47% in 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' Accounts Payables (Quarterly) stood at $303,000 in 2015, then soared by 266.34% to $1.1 million in 2016, then surged by 33.60% to $1.5 million in 2017, then skyrocketed by 78.02% to $2.6 million in 2018, then spiked by 128.91% to $6.3 million in 2019.
  • Its Accounts Payables stands at $6.3 million for Q1 2019, versus $2.6 million for Q4 2018 and $4.1 million for Q3 2018.